Publications

Evusheld fact sheet for health professionals

Evusheld® (tixagevimab and cilgavimab) by AstraZeneca Pty Ltd is the first medication for the pre-exposure prophylaxis of COVID-19 in Australia.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.